Open AccessSupportive approaches for Alzheimer Disease
Author(s) -
Nicole Davis,
Cristina C. Hendrix,
Jemma G. Superville
Publication year - 2011
Publication title -
the nurse practitioner/the nurse practitioner
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.15
H-Index - 21
eISSN - 1538-8662
pISSN - 0361-1817
DOI - 10.1097/01.npr.0000399724.54519.ae
Subject(s) - dementia , disease , medicine , alzheimer's disease , donepezil , cognitive decline , psychiatry , acetylcholinesterase , drug , psychology , biology , biochemistry , enzyme
Alzheimer disease (AD) accounts for most dementia diagnoses. Acetylcholinesterase inhibitors and antipsychotics are first-line drug therapies for cognitive decline and to manage neuropsychiatric symptoms, respectively. Because AD is relentlessly progressive, NPs will need to provide long-term support to patients and their caregivers.